Thursday, 18 July 2013

Effects of Metformin Dose on Cancer Risk Reduction in Patients with Type 2 Diabetes Mellitus

The magnitude of cancer risk reduction and prolonged cancer onset times produced by metformin in patients with type 2 diabetes depended on the dose of metformin, regardless of whether metformin was used alone or combined with other antidiabetic drugs (Pharmacotherapy)

No comments:

Post a Comment